Chimeric Therapeutics Ltd (ASX:CHM) Share Price and News - StockTrack

Market Cap (19-Sep) $4,960,185 (1,007th)	Close (30-Jun) $0.038 0 (0%)	Volume (30-Jun) 1,963,571	Shortsold (11-May) 1 (0.00%) (717th)
52w High $0.60	52w Low $0.083	P/E -	EPS -0.84

	Subject
	CHM CHM Ann: CORE NK Platform Phase 1 Clinical Data Presentation
	1 (current) 2 3
	CHM CHM Ann: CHIMERIC PARTNERS WITH BE THE MATCH BIOTHERAPIES
	CHM CHM Ann: Change in substantial holding - PH
	CHM CHM Ann: Change of Director's Interest Notice - PH
	CHM CHM Ann: Entitlement Offer Notice to Eligible Retail Shareholders
	CHM CHM Ann: Entitlement Offer Notice to Ineligible Retail Shareholders
	CHM CHM Ann: Appendix 2A
	CHM CHM Ann: Half Yearly Report and Accounts
	CHM CHM Ann: Successful completion of Institutional Entitlement Offer
	CHM CHM Ann: Appendix 3B (amended)
	CHM CHM Ann: Investor Presentation - Entitlement Offer
	CHM CHM Ann: Prospectus
	CHM CHM Ann: Appendix 3B
	CHM CHM Ann: Entitlement Offer to raise approximately $18.1 million
	CHM CHM Ann: Trading Halt
	CHM CHM Ann: 2nd dose cohort in CLTX CAR T (supplementary announcement)
	CHM CHM Ann: Research Agreement with Penn (supplementary announcement)
	CHM CHM Ann: Encouraging data from 2nd dose cohort in CLTX CAR T trial
	CHM CHM Ann: Notification regarding unquoted securities - CHM
	CHM CHM Ann: Kelly Thornburg appointed Vice President, Head of Quality
	CHM CHM Ann: Sponsored Research Agreement with University of Pennsylvania
	CHM CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CHM CHM Ann: Chimeric receives US patent covering CLTX CAR technology
	CHM CHM Ann: Response to Appendix 3Y Query
	CHM CHM Ann: Successful completion of 2nd dose cohort in CLTX CAR T trial
	CHM CHM Ann: Change of Director's Interest Notice - JC, CE & GM
	CHM CHM Ann: Key management changes for 2022
	CHM CHM Ann: Change in substantial holding - PH
	CHM CHM Ann: Change of Director's Interest Notice - PH
	CHM CHM Ann: CORE-NK CELL PLATFORM (supplementary announcement)
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Notification regarding unquoted securities - CHM
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Transformative Portfolio Expansion Presentation
	CHM CHM Ann: Webinar CHM Transforms Portfolio
	CHM CHM Ann: Results of Meeting
	CHM CHM Ann: AGM Presentation
	CHM CHM Ann: CLTX CAR T data shows regional control of tumour recurrence
	CHM CHM Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA
	CHM CHM Ann: FIRST MILESTONE ON PATH TO CDH17 CAR T CLINICAL TRIAL
	CHM CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CHM CHM Ann: Notice of Annual General Meeting/Proxy Form
	CHM CHM Ann: Corporate Governance Statement
	CHM CHM Ann: Appendix 4G
	CHM CHM Ann: Annual Report to shareholders
	CHM CHM Ann: CHM 1101 data accepted for presentation at SNO meeting
	CHM CHM Ann: Notification regarding unquoted securities - CHM
	CHM CHM Ann: European patent granted for CLTX technology used in CHM 1101
	CHM CHM Ann: Cellular therapy experts join Chimeric CI-SAB
	CHM CHM Ann: Partnership with OncoBay Clinical to advance CHM 1101

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	3,199,999	+0.00 (33.33%)
12-Sep	$0.00	1,621,588	0.00 (0.00%)
11-Sep	$0.00	4,147,698	0.00 (0.00%)
05-Sep	$0.00	33,560,043	+0.00 (50.00%)
04-Sep	$0.00	14,909,951	0.00 (33.33%)
03-Sep	$0.00	2,714,060	0.00 (0.00%)
29-Aug	$0.00	12,601,385	0.00 (0.00%)
28-Aug	$0.00	31,406,613	0.00 (0.00%)
22-Aug	$0.00	9,836	0.00 (0.00%)
21-Aug	$0.00	1,597,558	0.00 (0.00%)
15-Aug	$0.00	17,970,592	0.00 (14.29%)
14-Aug	$0.00	165,625	+0.00 (16.67%)
07-Aug	$0.00	4,812,305	0.00 (0.00%)
31-Jul	$0.00	3,775,000	0.00 (25.00%)
30-Jul	$0.00	312,291	+0.00 (33.33%)
4 up, 3 down, and 8 flat days

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

Chimeric Therapeutics Ltd Health Care

$0.038 0.001 (2.70%)

$0.038 0.001 (2.70%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices